A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Atypical Hemolytic Uremic Syndrome (aHUS) Clinical Trial

Official title:
A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Status Completed

Clinical Trial Summary

The objective of this retrospective trial is to assess safety and efficacy of eculizumab in aHUS patients treated outside of an Alexion-sponsored controlled clinical trial.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Atypical Hemolytic Uremic Syndrome
Atypical Hemolytic Uremic Syndrome (aHUS)
Azotemia
Hemolysis
Hemolytic-Uremic Syndrome
Syndrome

Clinical Trial Details

NCT number	NCT01770951
Study type	Observational
Source	Alexion
Contact
Status	Completed
Phase
Start date	August 31, 2009
Completion date	November 30, 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01755429` - To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients	N/A
Completed	`NCT01757431` - The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)	Phase 2
Not yet recruiting	`NCT06312644` - Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Completed	`NCT02949128` - Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)	Phase 3
Completed	`NCT03131219` - Study of Ravulizumab in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)	Phase 3